DK0485219T3 - Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser - Google Patents
Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelserInfo
- Publication number
- DK0485219T3 DK0485219T3 DK91310322.2T DK91310322T DK0485219T3 DK 0485219 T3 DK0485219 T3 DK 0485219T3 DK 91310322 T DK91310322 T DK 91310322T DK 0485219 T3 DK0485219 T3 DK 0485219T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- atom
- oxygen
- heteroazolidine
- medicines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2301518A JP2997894B2 (ja) | 1990-11-07 | 1990-11-07 | 循環器系疾患の予防及び治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0485219T3 true DK0485219T3 (da) | 1996-07-22 |
Family
ID=17897897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91310322.2T DK0485219T3 (da) | 1990-11-07 | 1991-11-07 | Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0485219B1 (fr) |
JP (1) | JP2997894B2 (fr) |
AT (1) | ATE135212T1 (fr) |
DE (1) | DE69117879T2 (fr) |
DK (1) | DK0485219T3 (fr) |
ES (1) | ES2084120T3 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0719556B1 (fr) * | 1994-12-28 | 2000-10-25 | Sanwa Kagaku Kenkyusho Co., Ltd. | Utilisation de (2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazoline]-2-carboxamide pour le traitement de la kératopathie |
PE20050249A1 (es) * | 2003-07-25 | 2005-06-01 | Aventis Pharma Gmbh | Nuevas cianopirrolididas y procedimiento para su preparacion como medicamentos |
US7094800B2 (en) | 2003-07-25 | 2006-08-22 | Sanofi-Aventis Deutschland Gmbh | Cyanopyrrolidides, process for their preparation and their use as medicaments |
EP1961420B1 (fr) | 2005-12-16 | 2012-07-25 | Sanwa Kagaku Kenkyusho Co., Ltd | Agent destine a la prevention et au traitement de l'insuffisance renale aigue |
CA2642933A1 (fr) * | 2006-02-20 | 2007-08-30 | Sanwa Kagaku Kenkyusho Co., Ltd. | Agent prophylactique ou therapeutique pour les lesions dues a l'ischemie cerebrale ou les lesions dues a l'ischemie cerebrale avec reperfusion dans l'accident vasculaire cerebral |
EP2110141B1 (fr) | 2007-01-31 | 2013-04-03 | Sanwa Kagaku Kenkyusho Co., Ltd | Agent protecteur pour le nerf retinien ou le nerf optique |
WO2011087066A1 (fr) | 2010-01-14 | 2011-07-21 | 株式会社三和化学研究所 | Produit pharmaceutique destiné au traitement prophylactique ou thérapeutique de troubles accompagnés d'une angiogenèse oculaire et/ou d'une perméabilité vasculaire oculaire supérieure à la normale |
US20130005698A1 (en) * | 2010-04-28 | 2013-01-03 | University Of Tsukuba | Pharmaceutical for preventing or treating an inner ear disorder |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60181081A (ja) * | 1984-02-29 | 1985-09-14 | Kaken Pharmaceut Co Ltd | 新規ビスベンゾフラニルケトン誘導体 |
JPS61200991A (ja) * | 1985-03-04 | 1986-09-05 | Sanwa Kagaku Kenkyusho:Kk | スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤 |
JP2754644B2 (ja) * | 1988-12-29 | 1998-05-20 | 株式会社ツムラ | 新規リグナン類およびリグナン類を有効成分とする5―リポキシゲナーゼ阻害剤およびアルドースリダクターゼ阻害剤 |
US5164391A (en) * | 1989-09-20 | 1992-11-17 | Sanwa Kagaku Kenkyusho Co., Ltd. | Hydantoin derivatives for treating complications of diabetes and circulatory diseases |
-
1990
- 1990-11-07 JP JP2301518A patent/JP2997894B2/ja not_active Expired - Lifetime
-
1991
- 1991-11-07 DK DK91310322.2T patent/DK0485219T3/da active
- 1991-11-07 DE DE69117879T patent/DE69117879T2/de not_active Expired - Fee Related
- 1991-11-07 AT AT91310322T patent/ATE135212T1/de not_active IP Right Cessation
- 1991-11-07 EP EP91310322A patent/EP0485219B1/fr not_active Expired - Lifetime
- 1991-11-07 ES ES91310322T patent/ES2084120T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0485219B1 (fr) | 1996-03-13 |
DE69117879T2 (de) | 1996-08-08 |
DE69117879D1 (de) | 1996-04-18 |
JP2997894B2 (ja) | 2000-01-11 |
JPH04173791A (ja) | 1992-06-22 |
EP0485219A2 (fr) | 1992-05-13 |
ES2084120T3 (es) | 1996-05-01 |
ATE135212T1 (de) | 1996-03-15 |
EP0485219A3 (en) | 1992-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI831604A0 (fi) | Pyridinderivat, deras framstaellning och anvaendning | |
NO901300D0 (no) | Behandling og forbindelser. | |
MX9306831A (es) | Nuevos compuestos heterociclicos. | |
IE802612L (en) | Bicyclo £2.2.1| heptane derivatives | |
DE69935718D1 (de) | Antidiabetische medikamente | |
NO975666D0 (no) | Pyrroldovater og medisinsk sammensetning | |
AR002761A1 (es) | Un compuesto derivado del triazol, su uso, una composicion farmaceutica que lo contiene, un metodo de tratamiento o prevencion de una infeccion fungica enun paciente humano mediante dicho compuesto o composicion, y procedimiento y compuestos intermedios para prepararlo. | |
DK0652002T3 (da) | Anvendelse af 2-phenyl-3-aroylebenzothiophener til fremstilling af et medikament til hæmning af brusknedbrydning | |
DK0485219T3 (da) | Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser | |
FI941863A (fi) | Oksatsolidonijohdannainen | |
DE60009517D1 (de) | A-500359-derivate | |
MX9206930A (es) | Nuevos compuestos | |
DE69001004T2 (de) | Zusammensetzung gegen leberkrankheiten. | |
DE69428206T2 (de) | Chinolincarbonsäurederivate und ihre salze | |
DK360388A (da) | Laegemiddel til behandling af hjerteinsufficiens | |
ATE132748T1 (de) | Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres |